| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | AP-2 adaptor complex | 3.70e-04 | 14 | 43 | 2 | GO:0030122 | |
| GeneOntologyCellularComponent | clathrin coat of endocytic vesicle | 4.27e-04 | 15 | 43 | 2 | GO:0030128 | |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 8.47e-04 | 21 | 43 | 2 | GO:0030132 | |
| Domain | Ig_I-set | 8.59e-04 | 190 | 42 | 4 | IPR013098 | |
| Domain | I-set | 8.59e-04 | 190 | 42 | 4 | PF07679 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 15225646 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 11116144 | ||
| Pubmed | GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. | 8.94e-06 | 4 | 43 | 2 | 9740802 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 16497798 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 21104742 | ||
| Pubmed | Differential RET signaling pathways drive development of the enteric lymphoid and nervous systems. | 1.15e-04 | 13 | 43 | 2 | 22855506 | |
| Pubmed | Mouse B-type lamins are required for proper organogenesis but not by embryonic stem cells. | 1.35e-04 | 14 | 43 | 2 | 22116031 | |
| Pubmed | Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus. | 1.55e-04 | 15 | 43 | 2 | 20473291 | |
| Pubmed | A radial glia-specific role of RhoA in double cortex formation. | 3.72e-04 | 23 | 43 | 2 | 22405202 | |
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 4.76e-04 | 26 | 43 | 2 | 33905568 | |
| Pubmed | 1.07e-03 | 162 | 43 | 3 | 25826454 | ||
| Pubmed | Defining the molecular character of the developing and adult kidney podocyte. | 1.07e-03 | 39 | 43 | 2 | 21931791 | |
| Interaction | GFRA4 interactions | 4.04e-06 | 2 | 41 | 2 | int:GFRA4 | |
| Cytoband | 2p21 | 2.65e-05 | 61 | 43 | 3 | 2p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p21 | 5.98e-05 | 80 | 43 | 3 | chr2p21 | |
| Cytoband | 19q13.32 | 2.22e-03 | 74 | 43 | 2 | 19q13.32 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.36e-08 | 194 | 41 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 2.43e-08 | 195 | 41 | 6 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.80e-07 | 187 | 41 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.44e-07 | 190 | 41 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 8.66e-07 | 191 | 41 | 5 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.66e-07 | 191 | 41 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.89e-07 | 192 | 41 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.12e-07 | 193 | 41 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 9.12e-07 | 193 | 41 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.12e-07 | 193 | 41 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.12e-07 | 193 | 41 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.12e-07 | 193 | 41 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.35e-07 | 194 | 41 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.35e-07 | 194 | 41 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 9.35e-07 | 194 | 41 | 5 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 9.59e-07 | 195 | 41 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 9.59e-07 | 195 | 41 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.59e-07 | 195 | 41 | 5 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.59e-07 | 195 | 41 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.59e-07 | 195 | 41 | 5 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.84e-07 | 196 | 41 | 5 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.84e-07 | 196 | 41 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.84e-07 | 196 | 41 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.01e-06 | 197 | 41 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.01e-06 | 197 | 41 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.03e-06 | 198 | 41 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-06 | 198 | 41 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-06 | 198 | 41 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.03e-06 | 198 | 41 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.06e-06 | 199 | 41 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 151 | 41 | 4 | 523dcd243c285a6b74830a93c82cca8784edd658 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 151 | 41 | 4 | f3406094ce79cc80398b82d58ca6fd87a96e68d4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 159 | 41 | 4 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.63e-05 | 166 | 41 | 4 | 0da2c6ea1e62f1aafabafbbfbbcc6f7011739346 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-05 | 174 | 41 | 4 | eb8012823b08729b462d1e5212f4873bb6b4eb1e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-05 | 174 | 41 | 4 | 32fdeeebeeeca657eac6329caad4c28ca54e4d1c | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB|TCGA-Thymus / Sample_Type by Project: Shred V9 | 2.00e-05 | 175 | 41 | 4 | 50f9b994bdd389158f92f891944ea81b2fb15eef | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-05 | 177 | 41 | 4 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-05 | 177 | 41 | 4 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 178 | 41 | 4 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 178 | 41 | 4 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 178 | 41 | 4 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 178 | 41 | 4 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.19e-05 | 179 | 41 | 4 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 180 | 41 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 180 | 41 | 4 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-05 | 181 | 41 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.28e-05 | 181 | 41 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 184 | 41 | 4 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 184 | 41 | 4 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-05 | 184 | 41 | 4 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-05 | 185 | 41 | 4 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-05 | 185 | 41 | 4 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-05 | 185 | 41 | 4 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 186 | 41 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.59e-05 | 187 | 41 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.59e-05 | 187 | 41 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 190 | 41 | 4 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-05 | 191 | 41 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 192 | 41 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.88e-05 | 192 | 41 | 4 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 2.94e-05 | 193 | 41 | 4 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 193 | 41 | 4 | 7631bf3362b4fa061ffeab4879ab12c4708dc4c0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 193 | 41 | 4 | 8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.94e-05 | 193 | 41 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 194 | 41 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.00e-05 | 194 | 41 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-05 | 194 | 41 | 4 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 194 | 41 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.00e-05 | 194 | 41 | 4 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 3.00e-05 | 194 | 41 | 4 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-05 | 194 | 41 | 4 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 3.06e-05 | 195 | 41 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 3.12e-05 | 196 | 41 | 4 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 41 | 4 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 41 | 4 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-05 | 197 | 41 | 4 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 3.18e-05 | 197 | 41 | 4 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | distal-mesenchymal-Fibromyocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.24e-05 | 198 | 41 | 4 | 9d1d95e7703cfc70a8ad427e400c340dbd205db8 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.24e-05 | 198 | 41 | 4 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 3.24e-05 | 198 | 41 | 4 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.24e-05 | 198 | 41 | 4 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.24e-05 | 198 | 41 | 4 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | distal-mesenchymal-Fibromyocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.24e-05 | 198 | 41 | 4 | fbfac1d10e4224990a094cc84b74bbc206881423 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.31e-05 | 199 | 41 | 4 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 199 | 41 | 4 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 199 | 41 | 4 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.31e-05 | 199 | 41 | 4 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.37e-05 | 200 | 41 | 4 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.37e-05 | 200 | 41 | 4 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 121 | 41 | 3 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.92e-04 | 122 | 41 | 3 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 3.17e-04 | 19 | 41 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | age-related hearing impairment | 1.05e-03 | 324 | 41 | 4 | EFO_0005782 | |
| Disease | triacylglycerol 50:3 measurement | 1.35e-03 | 39 | 41 | 2 | EFO_0010410 | |
| Disease | autistic disorder (is_implicated_in) | 1.57e-03 | 42 | 41 | 2 | DOID:12849 (is_implicated_in) | |
| Disease | age at initiation of smoking | 3.82e-03 | 66 | 41 | 2 | EFO_0021784 | |
| Disease | biological sex | 4.01e-03 | 230 | 41 | 3 | PATO_0000047 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGVQWRNLGSLQPLP | 326 | Q6UX73 | |
| GIWILAELRIQPGNP | 896 | P63010 | |
| SQLEGLAQALWLNPP | 276 | Q8NHS2 | |
| QLLWNPGILILDEPT | 226 | Q9H221 | |
| QPGIDLPSWILGILQ | 66 | Q4L235 | |
| LLPPALQGALQQWLG | 251 | Q5VUD6 | |
| LLVGAWTPLGAQNPI | 11 | Q9NRD9 | |
| QCLLTGGDPLPQLQW | 261 | Q8NFP4 | |
| QPPENWAEALGVLLG | 141 | Q86V59 | |
| ELPPELGQLGNLWQL | 586 | Q38SD2 | |
| QGDPLWVNVGLLLLS | 511 | Q8N370 | |
| LREPAQPGLWEQLGQ | 101 | O15054 | |
| SIAPQLLWNLGGPEK | 76 | A6NFC9 | |
| LPQAGLSPAEIQQLW | 256 | O15409 | |
| QPGPLQGWQLLALCV | 1036 | Q8IVE3 | |
| PSNWIEPLGGNAILN | 4356 | Q96RW7 | |
| PQNDSWIGLAPLNIP | 306 | Q9NXS3 | |
| LPGLVWDLGQQLGDL | 86 | Q96B18 | |
| SGWPPVLLDQLNPQG | 251 | Q9GZZ7 | |
| QGPWELQGILLLSQN | 571 | Q6NUI2 | |
| AWNLPLENPGIDIGD | 416 | Q6IS24 | |
| GLGQDRQVPLWGQLL | 216 | P50402 | |
| LIQWQPPRDESLNGL | 1596 | Q7Z5N4 | |
| PAQQVGPWLGQLQEL | 201 | Q9HA92 | |
| LPWLSPEVLQQNLQG | 241 | Q7RTN6 | |
| CDLLQQWDQLAPGLP | 1786 | Q6YHU6 | |
| PALLQPLAGAVGQLW | 171 | A2VEC9 | |
| PLANLQLLQVGDNPW | 186 | Q8N967 | |
| LGPNLLWPQAEGNIT | 406 | Q17R89 | |
| LGGLWEPGELQLLNV | 161 | Q16586 | |
| QSPGLGRPIWLQIAE | 311 | O75746 | |
| LGVLGPLDPQWLVEN | 501 | Q96LI5 | |
| PLLNENPQLSEGWEI | 186 | Q6NZY4 | |
| VLLDQPEIWGSGQPI | 216 | Q9BQI5 | |
| LPSNLWEGLRLGPLN | 526 | Q9H6E5 | |
| WEGLRLGPLNLQDPF | 531 | Q9H6E5 | |
| NDLWLVCEQPGLLPG | 261 | Q86SX3 | |
| PPDGQWGSQLLARQL | 101 | Q969T3 | |
| WLLVPNPEARLQQLG | 116 | Q9BRV3 | |
| LLGDINWIQPTLGIP | 271 | P63133 | |
| QAQGPPEPVDLLWLQ | 161 | P30530 | |
| PGLLQLWGLGTLQQE | 436 | Q8WUA4 | |
| LLLLSLQLGQGWGPD | 11 | O60542 | |
| PVLDLAQRQNGWLPI | 81 | P19404 |